QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study.

Bashar FteihaHani KaramehRamzi KurdBatsheva Ziff-WermanItamar FeldmanAlon BnayaSharon EinavAmir OrlevEli Ben-Chetrit

Published in: International journal of clinical practice (2020)

In patients treated with HCQ, QTc prolongation was associated with the presence of traditional risk factors such as hypokalaemia and furosemide treatment.

Keyphrases

risk factors
drug induced
sars cov
newly diagnosed
smoking cessation